Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Measuring and modelling the effects of systematic non-adherence to mass drug administration
Louise Dyson, Wilma A. Stolk, Sam H. Farrell, et al.
Epidemics (2017) Vol. 18, pp. 56-66
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The World Health Organization 2030 goals for onchocerciasis: Insights and perspectives from mathematical modelling

Gates Open Research (2019) Vol. 3, pp. 1545-1545
Open Access | Times Cited: 175
Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs
Jonathan I. D. Hamley, Philip Milton, Martin Walker, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 12, pp. e0007557-e0007557
Open Access | Times Cited: 171
Dynamics of COVID-19 under social distancing measures are driven by transmission network structure
Anjalika Nande, Ben Adlam, Justin Sheen, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 2, pp. e1008684-e1008684
Open Access | Times Cited: 105
Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis
Nathan C. Lo, David Gurarie, Nara Yoon, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 4
Open Access | Times Cited: 111
Schistosomiasis Control: Leave No Age Group Behind
Christina L. Faust, Derick Nii Mensah Osakunor, Jennifer A. Downs, et al.
Trends in Parasitology (2020) Vol. 36, Iss. 7, pp. 582-591
Open Access | Times Cited: 91
Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth Infections
Sam H. Farrell, Luc E. Coffeng, James E. Truscott, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S253-S259
Open Access | Times Cited: 86
The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission
Sam H. Farrell, James E. Truscott, Roy M. Anderson
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 67
Prospects for elimination of soil-transmitted helminths
Kristjana Ásbjörnsdóttir, Arianna Rubin Means, Marleen Werkman, et al.
Current Opinion in Infectious Diseases (2017) Vol. 30, Iss. 5, pp. 482-488
Open Access | Times Cited: 64
Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis
Nyamai Mutono, María‐Gloria Basáñez, Ananthu James, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 5, pp. e771-e782
Open Access | Times Cited: 6
Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review
James E. Wright, Marleen Werkman, Julia C. Dunn, et al.
Parasites & Vectors (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 58
How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
Suzanne Verver, Martin Walker, Young‐Eun Kim, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S267-S274
Open Access | Times Cited: 58
Public Health Policy Pillars for the Sustainable Elimination of Zoonotic Schistosomiasis
Eva Janoušková, Jessica Clark, Olumayowa T. Kajero, et al.
Frontiers in Tropical Diseases (2022) Vol. 3
Open Access | Times Cited: 26
Antimalarial mass drug administration in large populations and the evolution of drug resistance
Tran Dang Nguyen, Thu Nguyen-Anh Tran, Daniel M. Parker, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 7, pp. e0002200-e0002200
Open Access | Times Cited: 14
Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance
Moses Adriko, Christina L. Faust, Lauren V. Carruthers, et al.
Tropical Medicine and Infectious Disease (2018) Vol. 3, Iss. 4, pp. 111-111
Open Access | Times Cited: 44
The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling

Gates Open Research (2019) Vol. 3, pp. 1538-1538
Open Access | Times Cited: 37
Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic review
Rosie Maddren, Anna E. Phillips, Santiago Rayment Gomez, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 7, pp. e0010853-e0010853
Open Access | Times Cited: 11
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Klodeta Kura, Wilma A. Stolk, María‐Gloria Basáñez, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S93-S100
Open Access | Times Cited: 4
How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?
Klodeta Kura, Nyamai Mutono, María‐Gloria Basáñez, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S126-S130
Open Access | Times Cited: 4
Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti
Mary Chriselda Antony Oliver, Matthew Graham, Katherine Gass, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S160-S168
Open Access | Times Cited: 4
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in Cameroon between 1971 and 2020
Yannick Niamsi-Emalio, Hugues C. Nana-Djeunga, Claudio Fronterrè, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 3, pp. e0012250-e0012250
Open Access
Mass drug administration coverage and its determinants for the elimination of onchocerciasis in Ulanga District, Tanzania
Ambakisye Kuyokwa Mhiche, Dinah B. Gasarasi, George Kabona, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 4, pp. e0012219-e0012219
Open Access
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns
Jorge Cano, María‐Gloria Basáñez, Simon J. O’Hanlon, et al.
Parasites & Vectors (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
Anna Borlase, Seth Blumberg, E. Kelly Callahan, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 3, pp. 213-221
Open Access | Times Cited: 25
Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?
T. Déirdre Hollingsworth
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S237-S244
Open Access | Times Cited: 32
Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination
Thomas M. Lietman, Amy Pinsent, Fengchen Liu, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S275-S280
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top